Tohru Matsuura Selected Research

Tohru Matsuura Research Topics

Disease

8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2011 - 07/2010
7	Myotonic Dystrophy (Dystrophia Myotonica) 01/2016 - 01/2008
6	Infarction (Infarctions) 08/2011 - 07/2010
5	Ischemic Stroke 04/2013 - 01/2011
5	Brain Ischemia (Cerebral Ischemia) 01/2011 - 08/2010
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2005
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016 - 06/2010
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2012 - 01/2011
3	Stroke (Strokes) 06/2018 - 01/2011
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 11/2010 - 04/2009
3	Spinocerebellar Ataxia 10 04/2009 - 01/2006
2	Infections 12/2023 - 01/2021
2	Neoplasms (Cancer) 08/2016 - 08/2010
2	Brain Injuries (Brain Injury) 01/2011 - 08/2010
2	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 04/2009 - 12/2008
1	Meningitis 12/2023
1	Encephalitis (Encephalitis, Rasmussen) 12/2023
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021
1	Fragile X Tremor Ataxia Syndrome 01/2021
1	Spastic Paraplegia Type 4 01/2021
1	COVID-19 01/2021
1	Ataxia (Dyssynergia) 01/2021
1	Tremor (Tremors) 01/2021
1	Patent Foramen Ovale 06/2018
1	Varicose Veins (Varicose Vein) 06/2018
1	Paradoxical Embolism 06/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2016
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2015
1	Cerebral Hemorrhage 04/2013
1	Embolism (Embolus) 04/2013
1	Carotid Artery Diseases 12/2012
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2012
1	Osteogenesis Imperfecta (Lobstein Disease) 11/2011
1	Disease Progression 08/2011
1	Nervous System Diseases (Neurological Disorders) 07/2011
1	Cerebral Infarction 07/2011
1	Hypertension (High Blood Pressure) 03/2011
1	Cognitive Dysfunction 01/2011

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2010
6	RNA (Ribonucleic Acid)IBA 01/2016 - 01/2008
5	Atorvastatin (Lipitor)FDA Link 12/2012 - 01/2011
5	Neuroprotective AgentsIBA 08/2011 - 08/2010
4	Amlodipine (Norvasc)FDA LinkGeneric 12/2012 - 01/2011
3	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2018 - 11/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2003
2	SteroidsIBA 01/2021 - 01/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2016 - 01/2011
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2016 - 09/2014
2	atorvastatin drug combination amlodipine FDA Link 12/2012 - 08/2011
2	ElementsIBA 01/2012 - 01/2006
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2011 - 11/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2011 - 01/2011
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2011 - 08/2010
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2011 - 08/2010
2	Annexin A5IBA 12/2010 - 07/2010
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 12/2010 - 07/2010
2	salicylhydroxamic acid (SHAM)IBA 08/2010 - 07/2010
2	Heterogeneous-Nuclear Ribonucleoprotein Group F-HIBA 04/2009 - 12/2008
1	Immunoglobulin G (IgG)IBA 12/2023
1	Immunoglobulin M (IgM)IBA 12/2023
1	AntibodiesIBA 12/2023
1	protoporphyrin IXIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	SpastinIBA 01/2021
1	AcidsIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Diphosphonates (Bisphosphonates)IBA 08/2016
1	Fluvastatin FDA Link 08/2016
1	Zoledronic Acid (Zometa)FDA Link 08/2016
1	2- (2- methoxy- 4- nitrophenyl)- 3- (4- nitrophenyl)- 5- (2,4- disulfophenyl)- 2H tetrazolium monosodium saltIBA 08/2016
1	Protein AggregatesIBA 01/2016
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2016
1	Phenylbutazone (Butazolidin)FDA Link 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 01/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2015
1	EnzymesIBA 01/2015
1	EdaravoneIBA 04/2013
1	Warfarin (Coumadin)FDA LinkGeneric 04/2013
1	Synapsins (Synapsin I)IBA 03/2013
1	mitochondrial transcription factor AIBA 06/2012
1	Aquaporin 4IBA 01/2012
1	OrexinsIBA 01/2012
1	anti-aquaporin 4 autoantibodyIBA 01/2012
1	alpha2 Subunit Collagen Type IIBA 11/2011
1	Biomarkers (Surrogate Marker)IBA 08/2011
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 08/2011
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2011
1	Biotin (Vitamin H)FDA Link 08/2011
1	Hematoxylin (Haematoxylon)IBA 08/2011
1	OccludinIBA 07/2011
1	PlatinumIBA 07/2011
1	CollagenIBA 07/2011
1	Superoxides (Superoxide)IBA 07/2011
1	CholesterolIBA 01/2011

Therapy/Procedure

5	Therapeutics 06/2018 - 11/2010
1	Mechanical Ventilators (Ventilator) 01/2021
1	Sclerotherapy 06/2018
1	Thrombolytic Therapy 04/2013